Swiss Semiconductors Stock News

Dottikon ES Holding (VTX:DESN) has had a great run on the share market with its stock up by a significant 18% over the...

It is hard to get excited after looking at Clariant's (VTX:CLN) recent performance, when its stock has declined 12...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Vetropack Holding AG's ( VTX:VETN ) price-to-earnings (or "P/E") ratio of 28.5x might make it look like a sell right...

Basilea Pharmaceutica's (VTX:BSLN) stock is up by a considerable 17% over the past month. Given that the market rewards...

If you want to compound wealth in the stock market, you can do so by buying an index fund. But investors can boost...

Sika (SWX:SIKA) just pulled back the curtain on its Fast Forward program, a multi year push to digitize its value chain, streamline operations, and reshape its footprint, especially in China. See our latest analysis for Sika. The Fast Forward announcement lands after a tough stretch, with the share price down sharply on a year to date basis and the one year total shareholder return also deeply negative. This suggests sentiment has cooled even as management signals a profitability reset. If...

It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make...

One simple way to benefit from the stock market is to buy an index fund. But if you choose individual stocks with...

With a price-to-earnings (or "P/E") ratio of 21.9x Flughafen Zürich AG ( VTX:FHZN ) may be sending bearish signals at...

As European markets experience mixed returns, with the STOXX Europe 600 Index inching higher amid hopes for interest rate cuts, investors are increasingly focused on identifying value opportunities in this uncertain economic environment. In such conditions, stocks trading below their fair value can present attractive prospects for those seeking to capitalize on potential market inefficiencies and long-term growth potential.

As European markets navigate mixed returns amid hopes for interest rate cuts in the U.S. and UK, growth companies with high insider ownership are gaining attention for their potential resilience and alignment of interests between management and shareholders. In this environment, stocks that exhibit strong growth prospects coupled with significant insider ownership may offer a compelling combination of strategic vision and vested interest in long-term success.

Most readers would already be aware that Kuehne + Nagel International's (VTX:KNIN) stock increased significantly by...

With its stock down 7.3% over the past three months, it is easy to disregard Schindler Holding (VTX:SCHN). However...

Stock pickers are generally looking for stocks that will outperform the broader market. And while active stock picking...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it seems the smart money knows that...

There wouldn't be many who think HT5 AG's ( VTX:HT5 ) price-to-sales (or "P/S") ratio of 0.2x is worth a mention when...

The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says...

ABB (SWX:ABBN) just bought back nearly 300,000 shares as part of its ongoing 2025 repurchase program, a steady signal that management prefers returning cash to investors instead of chasing every acquisition opportunity. See our latest analysis for ABB. That steady buying has come alongside firm price momentum, with the share price at CHF 58.68 and a robust year to date share price return of 19.37 percent. The five year total shareholder return of 191.81 percent shows that ABB’s long term...

Cosmo Pharmaceuticals has reported strong top-line Phase III results for clascoterone 5% topical solution in male androgenetic alopecia and, together with Glenmark Pharmaceuticals, secured European Commission marketing authorization for Winlevi (clascoterone 10 mg/g cream) to treat acne vulgaris in 17 countries. These developments highlight clascoterone’s potential as a versatile, first-in-class topical androgen receptor inhibitor across both hair loss and acne, expanding Cosmo’s...

Temenos (SWX:TEMN) has quietly climbed about 6% over the past week and more than 30% in the past 3 months, putting fresh attention on whether this banking software specialist’s rebound still has room to run. See our latest analysis for Temenos. That recent momentum builds on a solid recovery trend, with a strong 90 day share price return helping push year to date gains higher. A 1 year total shareholder return above 35% suggests confidence is slowly coming back after a tougher multi year...

Adecco Group (SWX:ADEN) has been drifting lower over the past month, and that quiet slide is exactly why the stock is interesting now, especially given its improving earnings backdrop and deep valuation discount. See our latest analysis for Adecco Group. At around CHF 21.96 per share, Adecco’s roughly 6 percent 3 month share price decline contrasts with stabilising year to date performance, while a 5 year total shareholder return near minus 48 percent shows how heavily sentiment has reset...

Nestlé (SWX:NESN) has been quietly grinding higher this year, and that slow, steady move is starting to catch investors attention as they reassess what they are paying for its global food empire. See our latest analysis for Nestlé. After a soft patch in prior years, Nestlé’s roughly mid single digit year to date share price return has been backed by improving sales and earnings, hinting that investors are slowly rebuilding confidence after a weaker three year total shareholder return. If...

The Cosmo Pharmaceuticals N.V. ( VTX:COPN ) share price has done very well over the last month, posting an excellent...